据EndpointsNews报道,前美国食品药品管理局(FDA)药物评估和研究中心主任Patrizia Cavazzoni已经以“首席医疗官”身份加入辉瑞制药(Pfizer),并将向该公司首席科学官Chris Boshoff汇报工作。。据悉,Patrizia Cavazzoni于今年1月离职FDA,她将领导辉瑞集团的监管、安全和医疗业务。Cavazzoni在FDA期间对许多重要药物的审核和批准过程...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.